Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

OBJECTIVES: The BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3, a cell collection device coupled with the biomarker trefoil factor 3, as a tool for detecting Barrett’s oesophagus, a precursor of oesophageal adenocarcinoma (OAC), in primary care. In this nested st...

Descripción completa

Detalles Bibliográficos
Autores principales: Maroni, Roberta, Barnes, Jessica, Offman, Judith, Scheibl, Fiona, Smith, Samuel G, Debiram-Beecham, Irene, Waller, Jo, Sasieni, Peter, Fitzgerald, Rebecca C, Rubin, Greg, Walter, Fiona M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990713/
https://www.ncbi.nlm.nih.gov/pubmed/35393308
http://dx.doi.org/10.1136/bmjopen-2021-054258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990713/
https://www.ncbi.nlm.nih.gov/pubmed/35393308
http://dx.doi.org/10.1136/bmjopen-2021-054258

Ejemplares similares